Drug recall · December 21, 2022
Lacosamide Oral Solution recall
Why: Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured By: HETERO LABS LIMITED, Jeedimetla, Hyderabad - 500 055, India, NDC 31722-627-26
- Lots / codes
Lot#: E222200, E222199, Exp 05/2024; E222228, Exp 06/2024
- Quantity
- N/A
- Company
- Camber Pharmaceuticals, Inc, Piscataway, NJ
- Distribution
- USA Nationwide
- Initiated
- December 6, 2022 · Voluntary: Firm initiated
- Classified
- December 28, 2022
- Reported
- December 21, 2022
- Ended
- March 15, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lacosamide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.